Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference

Rhea-AI Summary

Apogee Therapeutics (NASDAQ: APGE) has announced its participation in the upcoming Bank of America Health Care Conference. The company's management team will deliver a presentation on Tuesday, May 13, 2025, at 1:40 p.m. PT / 4:40 p.m. ET. Interested parties can access both the live and archived versions of the presentation through the News & Events page in the Investors section of Apogee Therapeutics' website.

News Market Reaction – APGE

-0.13%

-0.13% Session move

In the trading session that priced this news, APGE declined 0.13%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN FRANCISCO and BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will present at the Bank of America Health Care Conference on Tuesday, May 13, 2025, at 1:40 p.m. P.T. / 4:40 p.m. E.T.

A live and archived webcast of the presentation will be available via the News & Events page in the Investors section of the Apogee Therapeutics website.

About Apogee

Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, including for the treatment of AD, asthma, EoE, COPD and other I&I indications. Apogee’s antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. APG777, the company’s most advanced program, is being initially developed for the treatment of AD, which is the largest and one of the least penetrated I&I markets. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today’s standard of care. For more information, please visit https://apogeetherapeutics.com.

Investor Contact:
Noel Kurdi
VP, Investor Relations
Apogee Therapeutics, Inc.
noel.kurdi@apogeetherapeutics.com

Media Contact:
Dan Budwick
1AB
dan@1abmedia.com

FAQ

When is Apogee Therapeutics (APGE) presenting at the Bank of America Health Care Conference 2025?

Apogee Therapeutics will present at the Bank of America Health Care Conference on Tuesday, May 13, 2025, at 1:40 p.m. PT / 4:40 p.m. ET.

How can I watch Apogee Therapeutics' (APGE) presentation at the Bank of America Healthcare Conference?

The presentation can be accessed through a live and archived webcast available on the News & Events page in the Investors section of Apogee Therapeutics' website.

What is the stock symbol for Apogee Therapeutics?

Apogee Therapeutics trades on the Nasdaq under the symbol APGE.

Where is the Bank of America Healthcare Conference 2025 presentation by APGE being held?

While the specific venue is not mentioned in the press release, the company will present at the Bank of America Health Care Conference, with times given in PT and ET.